Target
Cytochrome P450 2C9
Ligand
BDBM597562
Substrate
n/a
Meas. Tech.
ChEMBL_2245903 (CHEMBL5160113)
IC50
4500±n/a nM
Citation
 Taft, BRYokokawa, FKirrane, TMata, ACHuang, RBlaquiere, NWaldron, GZou, BSimon, OVankadara, SChan, WLDing, MSim, SStraimer, JGuiguemde, ALakshminarayana, SBJain, JPBodenreider, CThompson, CLanshoeft, CShu, WFang, EQumber, JChan, KPei, LChen, YLSchulz, HLim, JAbas, SNAng, XLiu, YAngulo-Barturen, IJiménez-Díaz, MBGamo, FJCrespo-Fernandez, BRosenthal, PJCooper, RATumwebaze, PAguiar, ACCCampo, BCampbell, SWagner, JDiagana, TTSarko, C Discovery and Preclinical Pharmacology of INE963, a Potent and Fast-Acting Blood-Stage Antimalarial with a High Barrier to Resistance and Potential for Single-Dose Cures in Uncomplicated Malaria. J Med Chem 65:3798-3813 (2022) [PubMed] 
Target
Name:
Cytochrome P450 2C9
Synonyms:
(R)-limonene 6-monooxygenase | (S)-limonene 6-monooxygenase | CP2C9_HUMAN | CYP2C10 | CYP2C9 | CYPIIC9 | Cytochrome P450 2C9 (CYP2C9 ) | Cytochrome P450 2C9 (CYP2C9) | P-450MP | P450 MP-4/MP-8 | P450 PB-1 | S-mephenytoin 4-hydroxylase
Type:
Enzyme
Mol. Mass.:
55636.33
Organism:
Homo sapiens (Human)
Description:
P11712
Residue:
490
Sequence:
MDSLVVLVLCLSCLLLLSLWRQSSGRGKLPPGPTPLPVIGNILQIGIKDISKSLTNLSKVYGPVFTLYFGLKPIVVLHGYEAVKEALIDLGEEFSGRGIFPLAERANRGFGIVFSNGKKWKEIRRFSLMTLRNFGMGKRSIEDRVQEEARCLVEELRKTKASPCDPTFILGCAPCNVICSIIFHKRFDYKDQQFLNLMEKLNENIKILSSPWIQICNNFSPIIDYFPGTHNKLLKNVAFMKSYILEKVKEHQESMDMNNPQDFIDCFLMKMEKEKHNQPSEFTIESLENTAVDLFGAGTETTSTTLRYALLLLLKHPEVTAKVQEEIERVIGRNRSPCMQDRSHMPYTDAVVHEVQRYIDLLPTSLPHAVTCDIKFRNYLIPKGTTILISLTSVLHDNKEFPNPEMFDPHHFLDEGGNFKKSKYFMPFSAGKRICVGEALAGMELFLFLTSILQNFNLKSLVDPKNLDTTPVVNGFASVPPFYQLCFIPV
  
Inhibitor
Name:
BDBM597562
Synonyms:
US11597733, Example 4-0
Type:
Small organic molecule
Emp. Form.:
C19H26N6O2S
Mol. Mass.:
402.514
SMILES:
COc1nc(ccc1-c1cnc2sc(nn12)N1CCC(O)(CN)CC1)C(C)C
Structure:
Search PDB for entries with ligand similarity: